Evidence map›Paper›PMID 30605522›Full record

ArticleNucleic acids research2019

YB-1, an abundant core mRNA-binding protein, has the capacity to form an RNA nucleoprotein filament: a structural analysis.

Dmitry A Kretov, Marie-Jeanne Clément, Guillaume Lambert, Dominique Durand, Dmitry N Lyabin, Guillaume Bollot, Cyril Bauvais, Anastasiia Samsonova, Karina Budkina, Rachid C Maroun and 8 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Genetic variants in RNA mCancer medicine · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Dmitry A KretovInstitute of Protein Research, Russian Academy of Sciences, Pushchino 142290, Russian Federation.
Marie-Jeanne ClémentSABNP, University of Evry, INSERM U1204, Université Paris-Saclay, 91025 Evry, France.
Guillaume LambertSABNP, University of Evry, INSERM U1204, Université Paris-Saclay, 91025 Evry, France.
Dominique DurandInstitute for Integrative Biology of the Cell (I2BC), CEA, CNRS, Université Paris-Sud, Université Paris-Saclay, 91198 Gif-sur-Yvette, France.
Dmitry N LyabinInstitute of Protein Research, Russian Academy of Sciences, Pushchino 142290, Russian Federation.
Guillaume BollotSynsight, a/s IncubAlliance 86 rue de Paris Orsay 91400, France.
Cyril BauvaisSynsight, a/s IncubAlliance 86 rue de Paris Orsay 91400, France.
Anastasiia SamsonovaSABNP, University of Evry, INSERM U1204, Université Paris-Saclay, 91025 Evry, France.
Karina BudkinaInstitute of Protein Research, Russian Academy of Sciences, Pushchino 142290, Russian Federation.
Rachid C MarounSABNP, University of Evry, INSERM U1204, Université Paris-Saclay, 91025 Evry, France.
Loic HamonSABNP, University of Evry, INSERM U1204, Université Paris-Saclay, 91025 Evry, France.
Ahmed BouhssSABNP, University of Evry, INSERM U1204, Université Paris-Saclay, 91025 Evry, France.
Ewen LescopInstitut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Saclay, 91198 Gif sur Yvette cedex, France.
Flavio TomaSABNP, University of Evry, INSERM U1204, Université Paris-Saclay, 91025 Evry, France.
Patrick A CurmiSABNP, University of Evry, INSERM U1204, Université Paris-Saclay, 91025 Evry, France.
Alexandre MaucuerSABNP, University of Evry, INSERM U1204, Université Paris-Saclay, 91025 Evry, France.
Lev P OvchinnikovInstitute of Protein Research, Russian Academy of Sciences, Pushchino 142290, Russian Federation.
David PastréSABNP, University of Evry, INSERM U1204, Université Paris-Saclay, 91025 Evry, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The structural rearrangements accompanying mRNA during translation in mammalian cells remain poorly understood. Here, we discovered that YB-1 (YBX1), a major partner of mRNAs in the cytoplasm, forms a linear nucleoprotein filament with mRNA, when part of the YB-1 unstructured C-terminus has been truncated. YB-1 possesses a cold-shock domain (CSD), a remnant of bacterial cold shock proteins that have the ability to stimulate translation under the low temperatures through an RNA chaperone activity. The structure of the nucleoprotein filament indicates that the CSD of YB-1 preserved its chaperone activity also in eukaryotes and shows that mRNA is channeled between consecutive CSDs. The energy benefit needed for the formation of stable nucleoprotein filament relies on an electrostatic zipper mediated by positively charged amino acid residues in the YB-1 C-terminus. Thus, YB-1 displays a structural plasticity to unfold structured mRNAs into extended linear filaments. We anticipate that our findings will shed the light on the scanning of mRNAs by ribosomes during the initiation and elongation steps of mRNA translation.

Indexed as

Amino Acid SequenceCytoskeletonEscherichia coliHumansNucleoproteinsProtein BindingProtein BiosynthesisProtein FoldingRibosomesRNA-Binding ProteinsRNA, MessengerY-Box-Binding Protein 1NucleoproteinsRNA-Binding ProteinsRNA, MessengerY-Box-Binding Protein 1YBX1 protein, human

Identifiers

PMID30605522
PMCPMC6451097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.